Pulse Biosciences, Inc. (PLSE) revenue
Pulse Biosciences, Inc. (PLSE) reported revenue of $350.00K in fiscal 2025 (the year ended December 31, 2025). Figures as of 18 Nov 2026, 06:56 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Revenue, fiscal 2025
- $350.00K
- Highest on record
- $1.42Mfiscal 2021
- Lowest on record
- $350.00Kfiscal 2025
- Fiscal years on record
- 32021–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Pulse Biosciences, Inc. revenue, in more detail
Across the 3 fiscal years on record (2021–2025), the highest was $1.42M in fiscal 2021 and the lowest $350.00K in fiscal 2025.
Revenue by fiscal year
Pulse Biosciences, Inc. revenue, year by year
| Fiscal year | Revenue | Change | Year ended |
|---|---|---|---|
| 2025 | $350.00K | — | |
| 2022 | $700.00K | 50.6% down | |
| 2021 | $1.42M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
How to read it
Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.
Pulse Biosciences, Inc., figure by figure
- Pulse Biosciences, Inc. market cap
- Pulse Biosciences, Inc. earnings
- Pulse Biosciences, Inc. earnings per share (EPS)
- Pulse Biosciences, Inc. P/E ratio
- Pulse Biosciences, Inc. P/S ratio
- Pulse Biosciences, Inc. P/B ratio
- Pulse Biosciences, Inc. free cash flow
- Pulse Biosciences, Inc. operating margin
- Pulse Biosciences, Inc. dividend
- Pulse Biosciences, Inc. shares outstanding
- Pulse Biosciences, Inc. total debt
- Pulse Biosciences, Inc. cash on hand
- Pulse Biosciences, Inc. total assets
- Pulse Biosciences, Inc. return on equity (ROE)
- Pulse Biosciences, Inc. return on invested capital (ROIC)
Pulse Biosciences, Inc. (PLSE) overview: price, valuation and scorecard
Pulse Biosciences, Inc. revenue: questions and answers
What is Pulse Biosciences, Inc.'s revenue?
Pulse Biosciences, Inc. (PLSE) reported revenue of $350.00K in fiscal 2025 (the year ended December 31, 2025).
What are the highest and lowest revenue figures on record for Pulse Biosciences, Inc.?
Across the 3 fiscal years on record (2021–2025), the highest was $1.42M in fiscal 2021 and the lowest $350.00K in fiscal 2025.
How is Pulse Biosciences, Inc.'s revenue calculated?
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
Fiscal years are named for the calendar year they end in.
Learn: revenue
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Pulse Biosciences, Inc. (PLSE) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/PLSE/revenue
Underlying data: the company's filings with the SEC and Yahoo Finance.